propylthiouracil Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #20893

This CTD dossier owner and manufacturer boasts over 15 years of experience producing and distributing pharmaceuticals under GMP-WHO standards. They specialize in manufacturing a wide range of over 100 drugs, including prescription medications and potentially over-the-counter products. Their product portfolio spans various therapy areas, with specific examples mentioned like Alvalo Bocinor Victoria Newlevo and Mifepristone, suggesting possible cardiovascular, pain management, or women's health focus. They primarily serve partners and customers in both domestic and international markets across regions like the EU and North America. The company holds consistent GMP certifications and fosters strong relationships with over 50 production and consumption partners.

Propylthiouracil is a medication used to treat hyperthyroidism. Suppliers of propylthiouracil market it in the form of 50mg oral tablets. In use for over 70 years, propylthiouracil is currently included in the World Health Organization’s list of Essential Medicines that contains the most important medication recommended for a basic health system. The market for the drug is relatively consolidated, with a limited number of producers and suppliers competing for market share internationally. Propylthiouracil suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified propylthiouracil manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail price of 100 (50mg) tablets of propylthiouracil is approximately 30,00 EUR to 40,00 EUR.